Literature DB >> 3160513

Deficient immune function of peripheral blood mononuclear cells from patients with Gardner syndrome.

R P Warren, A M Stembridge, E J Gardner.   

Abstract

Genetic susceptibility to certain cancers is recognized as a contributor to malignancy in man and experimental animals. Colorectal adenocarcinoma associated with Gardner syndrome is considered to be a hereditary form of cancer in which family members are at increased risk because they inherit an autosomal dominant gene for adenomas of the colorectum. The adenomas, if untreated, transform into adenocarcinoma. The purpose of the current study was to characterize immune function in patients with Gardner syndrome since reports exist of immune defects in patients with other forms of hereditary cancer. An analysis of the ability of lymphocytes from the patients to be stimulated by the T cell mitogens, phytohaemmaglutinin and concanavalin A, revealed severely depressed responses by peripheral blood mononuclear cells (PBMC) from all of the patients studied. A depressed response by patient PBMC to the B cell mitogen, pokeweed mitogen, also was observed but the extent of depression was not statistically significant. Natural killer (NK) cell activity of the patients was studied to determine if a possible genetic defect in this function is associated with Gardner syndrome. PBMC from half of the patients had marginally depressed NK cell function. An enumeration of patient cells revealed a significantly lower ratio of T4 (helper) to T8 (suppressor) T cells, but normal percentages of rosette forming, 7.2 (Ia) positive and Leu 11 positive (NK) cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160513      PMCID: PMC1577193     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.

Authors:  R P Warren; R Storb; P L Weiden; E M Mickelson; E D Thomas
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

2.  Histocompatibility determinants, immune responsiveness and aging in man.

Authors:  L J Greenberg; E J Yunis
Journal:  Fed Proc       Date:  1978-04

3.  Lymphoreticular malignancies and immunologic abnormalities in a sibship.

Authors:  A I Potolsky; C W Heath; C E Buckley; D T Rowlands
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

4.  Familial gastric cancer and immunologic abnormalities.

Authors:  E T Creagan; J F Fraumeni
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

5.  Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.

Authors:  R Kiessling; G Petranyi; G Klein; H Wigzel
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

6.  Varied manifestations of a familial lymphoproliferative disorder.

Authors:  J F Fraumeni; W Wertelecki; W A Blattner; R D Jensen; B G Leventhal
Journal:  Am J Med       Date:  1975-07       Impact factor: 4.965

7.  Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.

Authors:  E H Steinhauer; A T Doyle; J Reed; A S Kadish
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Role of NK cells in tumour growth and metastasis in beige mice.

Authors:  J E Talmadge; K M Meyers; D J Prieur; J R Starkey
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

9.  Defective recognitive immunity in family aggregates of colon carcinoma.

Authors:  N T Berlinger; C Lopez; M Lipkin; J E Vogel; R A Good
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Low natural-killer-cell activity in familial melanoma patients and their relatives.

Authors:  P Hersey; A Edwards; M Honeyman; W H McCarthy
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more
  6 in total

1.  Studies on lymphocyte subpopulations and NK cell activities in epileptic patients.

Authors:  X L Wang; G X Shen; B Sun; N Su
Journal:  J Tongji Med Univ       Date:  1989

2.  Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.

Authors:  Tehila Azoulay; Ilana Slouzky; Michal Karmona; Margarita Filatov; Michal Hayun; Yishai Ofran; Galit Sarig; Shimrit Ringelstein-Harlev
Journal:  Cancer Immunol Immunother       Date:  2022-09-01       Impact factor: 6.630

3.  Tumor growth impedes natural-killer-cell maturation in the bone marrow.

Authors:  John O Richards; Xing Chang; Bradley W Blaser; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

4.  Immune abnormalities in patients with autism.

Authors:  R P Warren; N C Margaretten; N C Pace; A Foster
Journal:  J Autism Dev Disord       Date:  1986-06

5.  Natural killer cells: role in local tumor growth and metastasis.

Authors:  Inge Langers; Virginie M Renoux; Marc Thiry; Philippe Delvenne; Nathalie Jacobs
Journal:  Biologics       Date:  2012-04-05

Review 6.  Natural killer cells as helper cells in dendritic cell cancer vaccines.

Authors:  María Betina Pampena; Estrella Mariel Levy
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.